• About Us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Emial Whitelisting
No Result
View All Result
China Secrets Revealed
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock
No Result
View All Result
China Secrets Revealed
No Result
View All Result
Home Investing

One Medical shares up 70% on Thursday: explained here

by
July 21, 2022
in Investing
0
One Medical shares up 70% on Thursday: explained here

One Medical (NASDAQ: ONEM) shares shot up nearly 70% on Thursday after Amazon.com Inc (NASDAQ: AMZN) said it will buy the tech-driven primary health care provider for $3.9 billion in cash, including debt.

Mark Mahaney reacts to the news on CNBC

Amazon is willing to pay $18 a share for the San Francisco-headquartered company that operates under 1Life Healthcare Inc. Reacting to the news on CNBC’s “TechCheck”, Mark Mahaney – Head of Internet Research at Evercore ISI said:

Amazon has been making forays into health care. They could either do it organically or through acquisitions. If acquisition, they needed a differentiated offering with a decent consumer brand. That’s where One Medical comes in.

In 2018, Amazon brought PillPack under its umbrella – a $750 million acquisition that helped the juggernaut to eventually launch its own online pharmacy. “AMZN” is not responding very notably this morning.

Amazon is set to report its Q2 financial results next week.

Amir Dan Rubin to remain the CEO of One Medical

One Medical has 767,000 members and 188 medical offices across 25 markets. The definitive agreement is yet to receive approval from its shareholders and is also subject to other customary closing conditions. Mahaney added:

I like the strategically sensible set up. I’d consider this an option package of Amazon. You don’t buy Amazon because of this deal, but you consider it a part of the option value of the company.

Upon completion of the transaction, Amir Dan Rubin will continue to serve as the Chief Executive of the Nasdaq-listed firm. One Medical had $90.9 million of net loss in its latest reported quarter.

The post One Medical shares up 70% on Thursday: explained here appeared first on Invezz.

Previous Post

The Canaries in the Coal Mines Are No Longer Singing

Next Post

Inflation to stay “undesirably high” as ECB hikes rates for the first time in over a decade

Next Post
Inflation to stay “undesirably high” as ECB hikes rates for the first time in over a decade

Inflation to stay “undesirably high” as ECB hikes rates for the first time in over a decade

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Review: It’s Not Free Speech

Review: It’s Not Free Speech

0
Rule, Britannia?

Rule, Britannia?

0

To Avoid Civil War, Learn to Tolerate Different Laws in Different States

0
How Much Did the US Government Pressure Twitter to Ban Alex Berenson?

How Much Did the US Government Pressure Twitter to Ban Alex Berenson?

0
Review: It’s Not Free Speech

Review: It’s Not Free Speech

August 15, 2022
Is China a Threat to the Fed? A Critique of the Portman Report

Is China a Threat to the Fed? A Critique of the Portman Report

August 15, 2022
Persimmon share price pressured ahead of earnings. Is it a buy?

Persimmon share price pressured ahead of earnings. Is it a buy?

August 15, 2022
This growth stock is worth owning despite higher rates: Gina Sanchez

This growth stock is worth owning despite higher rates: Gina Sanchez

August 14, 2022

Recent News

Review: It’s Not Free Speech

Review: It’s Not Free Speech

August 15, 2022
Is China a Threat to the Fed? A Critique of the Portman Report

Is China a Threat to the Fed? A Critique of the Portman Report

August 15, 2022
Persimmon share price pressured ahead of earnings. Is it a buy?

Persimmon share price pressured ahead of earnings. Is it a buy?

August 15, 2022
This growth stock is worth owning despite higher rates: Gina Sanchez

This growth stock is worth owning despite higher rates: Gina Sanchez

August 14, 2022

Disclaimer: ChinaSecretsRevealed.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Emial Whitelisting

Copyright © 2022 ChinaSecretsRevealed. All Rights Reserved.

No Result
View All Result
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock

Copyright © 2022 ChinaSecretsRevealed. All Rights Reserved.